CYP19A1 and breast carcinoma: Bollet et al. (31) analyzed the relationship between locoregional recurrence, clinical pathological factors, and intratumoral levels of gene expression of 17 proliferative genes, including the CYP19A1 gene, in women with premenopausal breast cancer.